NHS England asks: what treatments should we be investing in?
NHS England has launched a new consultation about how it should prioritise which specialised services and treatments to invest in.
Read MoreNHS England has launched a new consultation about how it should prioritise which specialised services and treatments to invest in.
Read MoreThe long-term use of certain medications with anticholinergic effects, such as antidepressants, hay fever and allergy treatments and sleep aids, could be linked to an increased risk of dementia, US researchers warn.
Read MorePatients in countries whose healthcare systems’ reimbursement decisions consider how much a cancer treatment costs per quality-adjusted life year achieved (CPQ) have less access to new cancer drugs than those in countries which do not use CPQ, according to a new study.
Read MoreProblems in hospitals are now spreading beyond A&E to other key areas of performance, increasing the risk of a crisis in the NHS, health policy think tank The King’s Fund has warned.
Read MoreThe treatment of whistleblowers remains a stain on the reputation of the NHS, and has not only led to “unwarranted and inexcusable pain” for some people but has also undermined the willingness of others to come forward – with ongoing implications for patient safety, MPs have warned.
Read More




PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
